Good long-term survival after childhood liver transplant

December 26, 2017

(HealthDay)—Liver transplantation in childhood is associated with good long-term survival, according to a study published online Dec. 15 in the American Journal of Transplantation.

Josefina Martinelli, M.D., from the Université Paris-Sud, and colleagues examined the outcomes of 128 children who underwent deceased from 1988 to 1993 (median age, 2.5 years). Participants were followed for a median of 24 years.

The researchers found that the 20-year patient survival rate was 79 percent and that the 20-year graft survival rate was 64 percent. Forty-two percent of survivors had elevated serum aminotransferase and/or gamma-glutamyl transferase activities after a single transplantation. In graft histology of 35 patients, 11 showed signs of chronic rejection and and five of biliary obstruction. Patients with abnormal and normal serum liver tests had mean total fibrosis scores of 4.5 and 3 out of 9, respectively. In 35 survivors, including four in end-stage renal disease who were undergoing dialysis or had undergone renal transplantation, the was less than 90 mL/min. The median final heights were 159 and 172 cm for women and men, respectively; in 37 patients, final height was below the target height.

"Twenty-year survival after childhood liver transplantation may be close to 80 percent, and final height is within the normal range for most patients," the authors write. "However, or altered liver biochemistries are present in over one-third of , which is a matter of concern for the future."

Explore further: 20-year survival expected for 4 out of 5 children who receive liver transplants

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

20-year survival expected for 4 out of 5 children who receive liver transplants

April 14, 2016
A new study presented today shows that 20-year survival after childhood liver transplantation can be expected for almost 80% of patients. The study, presented at The International Liver CongressTM 2016 in Barcelona, Spain, ...

ABO incompatible dual graft living donor liver transplant viable

August 3, 2017
(HealthDay)—Dual-graft (DG) adult living donor liver transplantation (ALDLT) with ABO-incompatible (ABOi) and ABO-compatible (ABOc) graft combination is associated with high rates of graft survival, with no significant ...

Drinking coffee may slow progression of liver disease

February 26, 2016
(HealthDay)—Regular coffee consumption seems to delay disease progression in alcoholic liver disease (ALD) and primary sclerosing cholangitis (PSC) patients with end-stage liver disease (ESLD) and increase long-term survival ...

First-degree relative grafts don't up liver disease recurrence

April 25, 2016
(HealthDay)—In liver transplantation (LT), patients who receive living donor grafts from first-degree relatives due to autoimmune liver diseases are not prone to increased disease recurrence, compared to those who receive ...

Good survival for HSCT-treated thalassemia patients

September 13, 2017
(HealthDay)—Patients with thalassemia treated with hematopoietic stem cell transplantation (HSCT) have 30-year survival that is similar to that of conventionally treated (CT) patients, according to a study published online ...

Long-term benefits to the liver-kidney transplant

April 15, 2016
A new study from physicians at Mayo Clinic in Rochester, found there may be long-term benefits to simultaneous liver-kidney transplantation versus kidney transplantation alone. The study, "Decreased Chronic Cellular and Antibody-Mediated ...

Recommended for you

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.